Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Harmenberg J., Akesson-Johansson A., Vrang L., Cox S. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine. AIDS Res Hum Retroviruses. 1990 Oct;6(10):1197–1202. doi: 10.1089/aid.1990.6.1197. [DOI] [PubMed] [Google Scholar]
- Jeffries D. J. Zidovudine after occupational exposure to HIV. BMJ. 1991 Jun 8;302(6789):1349–1351. doi: 10.1136/bmj.302.6789.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lange J. M., Boucher C. A., Hollak C. E., Wiltink E. H., Reiss P., van Royen E. A., Roos M., Danner S. A., Goudsmit J. Failure of zidovudine prophylaxis after accidental exposure to HIV-1. N Engl J Med. 1990 May 10;322(19):1375–1377. doi: 10.1056/NEJM199005103221907. [DOI] [PubMed] [Google Scholar]
- Looke D. F., Grove D. I. Failed prophylactic zidovudine after needlestick injury. Lancet. 1990 May 26;335(8700):1280–1280. doi: 10.1016/0140-6736(90)91343-9. [DOI] [PubMed] [Google Scholar]
- McCune J., Kaneshima H., Krowka J., Namikawa R., Outzen H., Peault B., Rabin L., Shih C. C., Yee E., Lieberman M. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol. 1991;9:399–429. doi: 10.1146/annurev.iy.09.040191.002151. [DOI] [PubMed] [Google Scholar]
- Namikawa R., Kaneshima H., Lieberman M., Weissman I. L., McCune J. M. Infection of the SCID-hu mouse by HIV-1. Science. 1988 Dec 23;242(4886):1684–1686. doi: 10.1126/science.3201256. [DOI] [PubMed] [Google Scholar]
- Ruprecht R. M., Chou T. C., Chipty F., Sosa M. G., Mullaney S., O'Brien L., Rosas D. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. J Acquir Immune Defic Syndr. 1990;3(6):591–600. [PubMed] [Google Scholar]
- Shih C. C., Kaneshima H., Rabin L., Namikawa R., Sager P., McGowan J., McCune J. M. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis. 1991 Mar;163(3):625–627. doi: 10.1093/infdis/163.3.625. [DOI] [PubMed] [Google Scholar]